AR225012A1 - Un procedimiento para preparar quinoleinas trans-dl-5-alquil(c1-c3)-4,4a,5,6,7,8,8a,9-octahidro-2h-pirrol(3,4-g)quinoleina - Google Patents

Un procedimiento para preparar quinoleinas trans-dl-5-alquil(c1-c3)-4,4a,5,6,7,8,8a,9-octahidro-2h-pirrol(3,4-g)quinoleina

Info

Publication number
AR225012A1
AR225012A1 AR277113A AR27711379A AR225012A1 AR 225012 A1 AR225012 A1 AR 225012A1 AR 277113 A AR277113 A AR 277113A AR 27711379 A AR27711379 A AR 27711379A AR 225012 A1 AR225012 A1 AR 225012A1
Authority
AR
Argentina
Prior art keywords
quinoleins
octahidro
pirrol
quinolein
alkyl
Prior art date
Application number
AR277113A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR225012A1 publication Critical patent/AR225012A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AR277113A 1979-01-22 1979-06-29 Un procedimiento para preparar quinoleinas trans-dl-5-alquil(c1-c3)-4,4a,5,6,7,8,8a,9-octahidro-2h-pirrol(3,4-g)quinoleina AR225012A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
AR225012A1 true AR225012A1 (es) 1982-02-15

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
AR277113A AR225012A1 (es) 1979-01-22 1979-06-29 Un procedimiento para preparar quinoleinas trans-dl-5-alquil(c1-c3)-4,4a,5,6,7,8,8a,9-octahidro-2h-pirrol(3,4-g)quinoleina

Country Status (25)

Country Link
EP (1) EP0013788B1 (es)
JP (1) JPS55100385A (es)
AR (1) AR225012A1 (es)
AT (1) AT365189B (es)
AU (1) AU528035B2 (es)
BE (1) BE877328A (es)
CA (1) CA1131227A (es)
CH (2) CH641801A5 (es)
DD (1) DD144668A5 (es)
DE (1) DE2965277D1 (es)
DK (1) DK268979A (es)
ES (1) ES482084A1 (es)
FI (1) FI65248C (es)
FR (2) FR2446833A1 (es)
GB (1) GB2040917B (es)
IE (1) IE48295B1 (es)
IL (1) IL57665A (es)
LU (1) LU81440A1 (es)
NZ (1) NZ190834A (es)
PH (2) PH15118A (es)
PL (1) PL125785B1 (es)
PT (1) PT69828A (es)
RO (1) RO77442A (es)
SU (1) SU1113006A3 (es)
ZA (1) ZA793244B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
DE3373468D1 (de) * 1983-06-03 1987-10-15 Lilly Co Eli Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
TW200904817A (en) * 2007-06-19 2009-02-01 Astrazeneca Ab Compounds and uses thereof
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
PT69828A (en) 1979-07-01
JPS6233233B2 (es) 1987-07-20
CH643258A5 (fr) 1984-05-30
FI65248B (fi) 1983-12-30
FR2446833B1 (es) 1982-03-05
RO77442A (ro) 1982-10-26
AT365189B (de) 1981-12-28
ES482084A1 (es) 1980-08-01
AU4844479A (en) 1980-07-31
PL125785B1 (en) 1983-06-30
FR2446835A1 (fr) 1980-08-14
PH16181A (en) 1983-07-25
IL57665A (en) 1982-11-30
DE2965277D1 (en) 1983-06-01
EP0013788B1 (en) 1983-04-27
GB2040917A (en) 1980-09-03
ZA793244B (en) 1981-02-25
PH15118A (en) 1982-08-10
CH641801A5 (fr) 1984-03-15
FI65248C (fi) 1984-04-10
NZ190834A (en) 1984-07-06
ATA452579A (de) 1981-05-15
FR2446833A1 (fr) 1980-08-14
BE877328A (fr) 1979-12-28
SU1113006A3 (ru) 1984-09-07
CA1131227A (en) 1982-09-07
LU81440A1 (fr) 1979-09-12
PL216721A1 (es) 1980-06-16
IE791210L (en) 1980-10-19
FI792047A (fi) 1980-07-23
AU528035B2 (en) 1983-04-14
EP0013788A1 (en) 1980-08-06
DD144668A5 (de) 1980-10-29
JPS55100385A (en) 1980-07-31
IL57665A0 (en) 1979-10-31
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
DK268979A (da) 1980-07-23
FR2446835B1 (es) 1982-04-23

Similar Documents

Publication Publication Date Title
ES507972A0 (es) Un procedimiento para preparar compuestos de cefem .
ES495376A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
AR221717A1 (es) Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES486425A0 (es) Un procedimiento para preparar nuevas 4-arilpiperinas.
ES497300A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES490290A0 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
ES490101A0 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
AR225012A1 (es) Un procedimiento para preparar quinoleinas trans-dl-5-alquil(c1-c3)-4,4a,5,6,7,8,8a,9-octahidro-2h-pirrol(3,4-g)quinoleina
ES508064A0 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES493760A0 (es) Un procedimiento para preparar benzoxazepinas.
DK238280A (da) Fremgangsmaade til fremstilling af 10,11-dihydro5h-dibenzo(a,d)cyclohepten-5,10-iminer
ES493497A0 (es) Un procedimiento para preparar 1,2-dihidro-2-oxo-5-(piridi- nil)nicotinonitrilo
ES482092A0 (es) Un procedimiento para preparar derivados de la ergolin.
ES494226A0 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
AR226418A1 (es) Un procedimiento para preparar compuestos de 2,4-dicloro-piridina
ES493191A0 (es) Un metodo para preparar feniliminotiadiazolinas
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina
ES498168A0 (es) Un procedimiento para preparar alcohilfosfonoditioato de al-cohilo
ES517458A0 (es) Un procedimiento para preparar un dentifrico estable.
ES487010A0 (es) Un procedimiento para preparar derivados de acido-3-aril- isoxazol-5-ilbenzoico.